City of Hope's Drs. Larry Kwak and Hong Qin discuss their research on BAFF-R CAR T therapy for leukemias and lymphomas. This material relates to a paper that appeared in the Sept. 25, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by H. Qin at Beckman Research Institute of City of Hope in Duarte, CA; and colleagues was titled, "CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies."
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission.